Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Community Care Physicians, P.C.
Age
18–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients who are willing to comply with the protocol requirements and can be contacted by telephone
Patients 18-60 years of age
Patients with clinically definite multiple sclerosis by Polman criteria
Patients with a history of MS as defined above with an EDSS between 3-6.
Patients with a significant stenosis of the internal jugular or azygos vein on the basis of magnetic resonance venography or Doppler ultrasound.
You may not be if
Patients with renal insufficiency based on an estimated GFR \<45
Patients with a known severe allergy to iodine or gadolinium-based contrast agents which cannot be adequately pre-medicated
Patients with a known allergy to nickel
Patients who pregnant
Patients with a contraindication to anticoagulation or anti-platelet medication
Patients with a contraindication to drugs used for conscious sedation during interventional procedures, including Versed and Fentanyl
Patients with a history of deep venous thrombosis of the lower extremities
Patients with occlusion of the right and left common femoral veins
Patients who have had any changes in their disease modifying drug regimen for MS during the 6 months prior to enrollment in this trial. This would include the addition of any new medications, a change in the dosage of any medications, or the removal of any medications from a patient's drug regimen
Patients with a life expectancy \<18 months
Patients who are currently enrolled or who plan to enroll in other investigations that conflict with follow-up testing or confounds data in this trial
Clareo Health | Evaluation of Angioplasty in the Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Multiple Sclerosis
